Insider · CIK 0001238325

RINGO WILLIAM R

Reports to the SEC for 16 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001238325

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-05	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2025-05-21	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2024-06-11	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2024-05-29	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+2,750 sh	—	—	2,750
2023-07-10	FTHFaeth Therapeutics, Inc.A Award	Director	AAward	+4,466 sh	—	—	23,399
2023-07-10	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.6K sh	—	—	14,550
2023-05-25	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-25	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-03-08	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.1K sh	—	—	29,100
2022-03-08	FTHFaeth Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	18,933
2022-03-08	FTHFaeth Therapeutics, Inc.A Award	Director	AAward	+8,933 sh	—	—	8,933
2021-05-20	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.6K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−52.4K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50.4K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.8K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−38K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40.9K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−49.6K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46.9K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34.5K sh	—	—	0
2021-04-16	FIVE PRIME THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-04-05	FIVE PRIME THERAPEUTICS, INC.G Gift	Director	GGift	−10K sh	—	—	0
2020-11-11	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−26K sh	—	—	52,408
2020-11-11	FIVE PRIME THERAPEUTICS, INC.S Sale	Director	SSale	−26K sh	$22.50	−$585K	10,000
2020-11-11	FIVE PRIME THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+26K sh	$2.80	+$72.8K	36,000
2020-11-11	FIVE PRIME THERAPEUTICS, INC.S Sale	Director	SSale	−53K sh	$22.50	−$1.19M	10,000
2020-11-11	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−53K sh	—	—	0
2020-11-11	FIVE PRIME THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+53K sh	$2.22	+$118K	62,959
2020-06-11	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-05-19	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+27.8K sh	—	—	27,769
2020-04-19	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+78.4K sh	—	—	78,408
2020-03-19	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+53K sh	—	—	52,959
2020-02-28	ASMBASSEMBLY BIOSCIENCES, INC.G Gift	Director	GGift	−2,000 sh	—	—	17,465
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-02-20	Dermira, Inc.Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.3K sh	—	—	0
2020-02-20	Dermira, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	$18.75	−$113K	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,620 sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.3K sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-02-19	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+38K sh	—	—	37,998
2020-01-20	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+40.9K sh	—	—	40,868
2020-01-20	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+40.9K sh	—	—	40,868
2019-12-19	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+49.6K sh	—	—	49,552
2019-11-19	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+50.4K sh	—	—	50,367

Recent filings

Accepted (ET)
Jun 94
RINGO WILLIAM R0000950170-25-083695
SEC(opens sec.gov)
May 234
RINGO WILLIAM R0001415889-25-014480
SEC(opens sec.gov)
Jun 134
RINGO WILLIAM R0001415889-24-016692
SEC(opens sec.gov)
May 304
RINGO WILLIAM R0000950170-24-066560
SEC(opens sec.gov)
Jul 124
RINGO WILLIAM R0001209191-23-042103
SEC(opens sec.gov)
May 304
RINGO WILLIAM R0001209191-23-032904
SEC(opens sec.gov)
May 274
RINGO WILLIAM R0001209191-22-032539
SEC(opens sec.gov)
Mar 94
RINGO WILLIAM R0001209191-22-017684
SEC(opens sec.gov)
May 244
RINGO WILLIAM R0001209191-21-035412
SEC(opens sec.gov)
Apr 194
RINGO WILLIAM R0001209191-21-027417
SEC(opens sec.gov)

Companies

Address

PFIZER INC. ATT: CORPORATE SECRETARY 235 EAST 42ND STREET

NEW YORK, NY, 10017